Kairos Ventures

Kairos Ventures, established in 2015 and headquartered in Beverly Hills, California, is a venture capital firm focused on investing in early-stage companies across life sciences, physical sciences, and technology sectors. The firm partners with leading scientists and universities to commercialize groundbreaking discoveries. Their portfolio includes notable companies like MemVerge, which aims to merge computer memory and storage using non-volatile RAM, and Neuro-Bio, a biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Another significant investment is MixComm, a developer of advanced 5G mmWave chips that enhance the efficiency and range of 5G base stations, which was acquired by Sivers Semiconductors in 2022. Kairos Ventures has made over 81 investments and achieved several exits, including Actinobac Biomed and MixComm. The firm is led by founder and CEO James Demetriades, along with a team of experienced professionals who provide strategic support to their portfolio companies.